A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural &； artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. A composition and method for the use of falcarinol for the the attenuation of Cannabis-induced dysphoria and reverse cannabis tolerance where the dosage of at least 30 mg can be effectively administered for buccal absorption.
